As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge

[ad_1] Daniel Acker | Bloomberg | Getty Images Drugmakers are jockeying to capitalize on the next major innovation coming to the blockbuster weight loss industry: effective, convenient and potentially affordable obesity pills.  An estimated 40% of U.S. adults are obese, making a successful pill a massive opportunity. It’s too early to crown a winner, especially…

Read More